Mechanistic study of novel arylpiperazine derivative NAF19 in prostate cancer treatment based on network pharmacology approach
By: Hua Jiang, Mingzhen Xu, Songsong Jiang, Weiqiang Huang and Hong Chen
Authors
Hua Jiang
Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University, China
Mingzhen Xu
Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University, China
Songsong Jiang
Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University, China
Weiqiang Huang
The Department of Biological and Pharmaceutical Sciences, Zhuhai Campus of Zunyi Medical University, China
Hong Chen
Luoyang Key Laboratory of Organic Functional Molecules, College of Food and Drug, Luoyang Normal University, China
Language: English
Page range: 27 - 38
Submitted on: Aug 21, 2025
Accepted on: Nov 12, 2025
Published on: Feb 5, 2026
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Hua Jiang, Mingzhen Xu, Songsong Jiang, Weiqiang Huang, Hong Chen, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.